These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15384418)

  • 1. Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.
    Reyes O; Torrens I; Ojalvo AG; Seralena A; Garay HE
    Mol Divers; 2004; 8(3):251-6. PubMed ID: 15384418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
    Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
    Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
    Torréns I; Ojalvo AG; Seralena A; Pupo E; Lugo V; Páez R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):230-6. PubMed ID: 10581194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic.
    Torrèns I; Ojalvo AG; Seralena A; Hayes O; de la Fuente J
    Immunol Lett; 1999 Dec; 70(3):213-8. PubMed ID: 10656677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction.
    Nilsson JB; Nilsson TK; Jansson JH; Boman K; Söderberg S; Näslund U
    J Intern Med; 2002 Nov; 252(5):405-11. PubMed ID: 12528758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the antigenic regions of streptokinase in humans before and after streptokinase therapy.
    Parhami-Seren B; Lynch M; White HD; Reed GL
    Mol Immunol; 1995 Jul; 32(10):717-24. PubMed ID: 7659098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralising antibodies after streptokinase treatment for myocardial infarction: a persisting puzzle.
    McGrath K; Hogan C; Hunt D; O'Malley C; Green N; Dauer R; Dalli A
    Br Heart J; 1995 Aug; 74(2):122-3. PubMed ID: 7546988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of a functional test of neutralising streptokinase antibodies for the prediction of the thrombolytic effect of streptokinase in acute myocardial infarction.
    Gill S; Kristensen SR; Haastrup B; Haghfelt T
    Cardiology; 2003; 100(1):36-40. PubMed ID: 12975544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
    Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
    Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptokinase-A Drug for Thrombolytic Therapy: A Patent Review.
    Kunamneni A; Durvasula R
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):106-21. PubMed ID: 26497671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indigenous recombinant streptokinase vs natural streptokinase in acute myocardial infarction patients: Phase III multicentric randomized double blind trial.
    Diwedi SK; Hiremath JS; Kerkar PG; Reddy KN; Manjunath CN; Ramesh SS; Prabhavati S; Dhobe M; Singh K; Bhusari P; Rao R
    Indian J Med Sci; 2005 May; 59(5):200-7. PubMed ID: 15985728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage.
    Parhami-Seren B; Keel T; Reed GL
    J Mol Biol; 1997 Aug; 271(3):333-41. PubMed ID: 9268662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity panning of peptide libraries using anti-streptokinase monoclonal antibodies: selection of an inhibitor of plasmin(ogen) active site.
    Parhami-Seren B; Krudysz J; Tsantili P
    J Immunol Methods; 2002 Sep; 267(2):185-98. PubMed ID: 12165440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a superior streptokinase for fibrinolytic therapy of vascular thrombosis.
    Keramati M; Mianroodi RA; Memarnejadian A; Mirzaie A; Sazvari S; Aslani MM; Roohvand F
    Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):218-29. PubMed ID: 23531210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does intravenous streptokinase therapy facilitate the formation of anti-heart antibodies in acute myocardial infarction?
    Scolozzi R; Boccafogli A; Vicentini L; Masotti M; Baraldi A; Pradella A; Baggioni GF; Camerani A; Boniotti A
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):297-300. PubMed ID: 2640051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.